Testoderm
Please select a testosterone article from the list below:
- Biotech Business - ALZA LICENSES DAPOXETINE FROM PPD GENUPRO.
- Journal of Family Practice - Direct-to-Consumer Prescription Drug Advertising, 1989-1998
- Medical Marketing and Media - Androderm leaflet attacked by FDA
- Business Wire - ALZA 1994 Annual Report Discloses New Products in Development, Cites Progress Toward Commercializing Products
- Biomedical Materials - INDUSTRY NEWS: Alza reports European approval of transdermal system and announces third quarter loss
- Biomedical Materials - Alza's transdermal testosterone system approved by FDA
- Biomedical Materials - PRODUCTS - TRANSDERMAL TESTOSTERONE DELIVERY SYSTEM
Thursday 1st of February 2001
Biotech Business - ALZA LICENSES DAPOXETINE FROM PPD GENUPRO.
Thursday 1st of February 2001, 12:00 amFebruary 1, 2001 -- PPD GenuPro, a research and development subsidiary of PPD, Inc. (Nasdaq: PPDI) and ALZA Corporation (NYSE: AZA) have announced that ALZA has...
Saturday 1st of April 2000
Journal of Family Practice - Direct-to-Consumer Prescription Drug Advertising, 1989-1998
Saturday 1st of April 2000, 12:00 amApril 1, 2000 -- A Content Analysis of Conditions, Targets, Inducements, and Appeals BACKGROUND * We conducted a content analysis of consumer-targeted prescription...
Monday 1st of February 1999
Medical Marketing and Media - Androderm leaflet attacked by FDA
Monday 1st of February 1999, 12:00 amFebruary 1, 1999 -- A leaflet stating, "Patients prefer Androderm over Testoderm TTS" was misleading, charged the DDMAC's Mark Askine in a November 25 letter to...
Tuesday 21st of March 1995
Business Wire - ALZA 1994 Annual Report Discloses New Products in Development, Cites Progress Toward Commercializing Products
Tuesday 21st of March 1995, 12:00 amMarch 21, 1995 -- PALO ALTO, Calif.--(BUSINESS WIRE)--March 21, 1995--ALZA Corporation (NYSE:AZA) identified four new products in development and cited progress toward...
Wednesday 1st of December 1993
Biomedical Materials - INDUSTRY NEWS: Alza reports European approval of transdermal system and announces third quarter loss
Wednesday 1st of December 1993, 12:00 amDecember 1, 1993 -- Five European countries have approved Alza Corp's 'Testoderm' testosterone transdermal system for commercial use. Austria, France, Germany,...
Monday 1st of November 1993
Biomedical Materials - Alza's transdermal testosterone system approved by FDA
Monday 1st of November 1993, 12:00 amNovember 1, 1993 -- A testosterone transdermal system developed by US company Alza Corp, based in California, has been cleared for marketing in the USA by the US Food...
Tuesday 1st of October 1991
Biomedical Materials - PRODUCTS - TRANSDERMAL TESTOSTERONE DELIVERY SYSTEM
Tuesday 1st of October 1991, 12:00 amOctober 1, 1991 -- A new drug application for a transdermal testosterone delivery system is currently on file with the US Food and Drug Administration (FDA),...